GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Medicinova, Inc. (MNOV) [hlAlert]

Medicinova, Inc., incorporated in September 2000, is a biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of diseases with unmet medical need with a specific focus on the United States market. Through strategic alliances primarily with Japanese pharmaceutical companies, the Company
is developing a portfolio of clinical and preclinical product candidates. Medicinova has acquired licenses to eight compounds for the development of 10 product candidates. Its development pipeline includes eight programs which have been in clinical development for the treatment of asthma, acute exacerbations of asthma, multiple sclerosis, or MS, interstitial cystitis (IC), solid tumor cancers, Generalized Anxiety Disorder/insomnia, preterm labor and urinary incontinence. The Company is focused on the development of two prioritized assets in its development pipeline: MN-221 for the treatment of status asthmaticus, and MN-166 for the treatment of MS.
.
( Total: 6 Current Stock Recommendations )
Medicinova, Inc.   (6)
Hold 17% Buy 83%
Related companies
Leucadia National ...   (1)
Buy 100%
Tomkins Plc   (1)
Buy 100%
Abb Ltd   (20)
Sell 20% Hold 40% Buy 40%
Dover Corporation   (20)
Hold 40% Buy 60%
Itt Industries, Inc.   (17)
Hold 53% Buy 47%
3m Company   (22)
Sell Hold 32% Buy 64%
7 DAYS GROUP ...   (4)
Hold 25% Buy 75%
Beam Inc Common ...   (18)
Sell Hold 61% Buy 28%
EXTERRAN HOLDINGS ...   (9)
Hold 33% Buy 67%
Resolute Forest ...   (12)
Sell 17% Hold 50% Buy 33%
Show  

Date (ET)MemberRatingYTD
Gains
 
5/24/2012  
Hold
  
10/18/2011  
Buy
  
6/22/2011  
Buy
  
1/4/2013  
Buy
  
7/9/2007  
Buy
  
5/15/2008  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy